Midi Health review

Women’s weight care without a membership fee

Midi Health offers virtual weight-management care in a broader women's-health setting, with clinical assessment, testing when appropriate and follow-up. The weight-care page explicitly says there is no membership fee. That can simplify the comparison with a recurring platform charge, but it does not make visits or medicine free. Its structure separates the professional appointment from the prescription purchase. This review assesses the published program, current prices and purchase terms. Midi is most relevant to someone who wants weight concerns considered with life stage and other health factors, while still comparing the exact product and full continuing cost.^[1]

For the connected decision, read the related evidence.

Visits and medicine are different budget lines

The current weight-management page lists a 30-minute initial self-pay visit at $250 and 15-minute returning visits at $150. It says qualifying insurance can cover visits, subject to the actual plan. Medication is priced separately. Ask how often follow-up is expected, whether labs create outside charges and what insurance cost sharing applies. A no-membership model can be attractive, but a comparison with a bundled service should include the likely appointment schedule. The right annual estimate cannot be made from one initial visit price or the lowest medication figure alone.^[1]

The compounded price table uses four weeks

Midi's dedicated pricing page labels its medication supply as four weeks, not a calendar month. It lists the compounded GLP-1 injectable from $165.90 to $355 and the dual-action GLP-1/GIP injectable from $210 to $434 across the displayed strengths. It also lists sublingual products separately, with their own prices. Shipping and supplies are described as included in those medication figures. These are product-table ranges, not a suggestion to select a dose for its price. The clinician determines whether treatment is appropriate. Ask which exact preparation and supply the personal quote covers before comparing it with a monthly offer elsewhere.^[2]

For the connected decision, read our support-model comparison.

Sublingual does not mean an approved oral tablet

The presence of a needle-free preparation can be appealing, but a compounded sublingual product should not be treated as interchangeable with an approved swallowed tablet or injection. Midi's disclosures state that compounded medications are not FDA approved. Shared ingredient or class terminology does not establish the same absorption, clinical outcomes or premarket review. Ask the clinician to identify the exact formulation and the evidence relevant to the proposed use. The lowest starting figure on the program page may correspond to a different format from the injection initially being compared. Those differences should stay visible rather than merged into a single generic GLP-1 price.^{[1] [2]}

Branded prescribing is a separate pathway

Midi says branded GLP-1 prescriptions can be sent to a pharmacy of the patient's choice, with cost dependent on coverage and drug price. The compound table therefore is not a price list for every branded medicine. Ask about authorization, pharmacy choice and the alternatives if a preferred product is not covered. A visit can provide useful medical advice even when the result is not a prescription, but the buyer should understand that possibility before booking primarily for medication access. Neither a clinical appointment nor a low starting compound price guarantees a particular branded treatment or its trial-average outcome.^[1]

For the connected decision, read our Tia Weight Care review.

Prescription refunds are restrictive

Midi's prescription support page says prescription treatments cannot be returned or refunded, with support available for errors. Its purchase terms say payment is due upon purchase and describe cancellation requests before shipment as subject to approval or denial in its discretion. Those statements should not be replaced with the more generous satisfaction language found on a separate supplement-store page. A buyer needs the policy for the actual prescription order. Before authorizing a recurring refill, clarify its charge timing and how to stop future orders. The absence of a parcel or tracking update is not an unconditional cancellation guarantee.^{[3] [4]}

Confirm appointment and refill administration separately

Because professional visits and medication purchases are separate, canceling one may not resolve the other. Obtain the current appointment late-cancellation policy and any product-specific refill agreement before relying on a particular deadline. The weight-care page does not provide a complete universal schedule for every future order. We would ask for the supply interval, later charges, renewal status and the responsible contact in writing. This is especially important when comparing four-week prescriptions with calendar-month memberships. A clear administrative plan supports continuity; it should remain understandable if treatment changes, the patient travels or insurance coverage is interrupted.

Our verdict

Midi is worth comparing for someone seeking women-focused weight care without a mandatory membership fee and with a clear separation between visits and medication. Its public self-pay visit prices and four-week product tables make several important costs visible. The remaining work is personal: verify insurance, the exact preparation, follow-up cadence and the prescription refund boundary. It is less suitable for someone who needs one flat recurring total without separate appointment planning. Choose it for an appropriate clinical relationship and transparent individual quote, with particular care around compounded sublingual claims and no assumption that the lowest displayed price buys the same product as another program.

Understanding the cost

No membership fee. Published self-pay visits are $250 initially and $150 for follow-up, with medication separate. Four-week compounded injectable ranges shown are $165.90–$355 for GLP-1 and $210–$434 for dual-action GLP-1/GIP, depending on the prescribed product strength. Sublingual products are separate. Prescription returns/refunds are restricted; confirm actual refill, appointment cancellation and order terms before payment.